Middle cerebral artery syndrome
Middle Cerebral Artery Syndrome[edit | edit source]
Middle Cerebral Artery Syndrome is a neurological condition resulting from compromised blood flow through the Middle Cerebral Artery (MCA). The MCA is a critical vessel in the brain's vascular system, predominantly affecting the lateral aspects of the frontal, temporal, and parietal lobes, as well as deep brain structures like the corona radiata, globus pallidus, caudate, and putamen. This article explores the pathophysiology, symptoms, diagnosis, and treatment of Middle Cerebral Artery Syndrome.
Pathophysiology[edit | edit source]
The MCA is the most common site for Ischemic Stroke, characterized by restricted blood supply. This restriction can lead to Infarction in the brain regions it supplies, primarily affecting the lateral aspects of the frontal, temporal, and parietal lobes, and certain deep brain structures. These areas are responsible for various cognitive and motor functions, and their impairment can lead to significant disability.
Clinical Features[edit | edit source]
Patients with Middle Cerebral Artery Syndrome may present with a variety of symptoms depending on the extent and location of the ischemia. Common symptoms include:
- Hemiparesis or hemiplegia (weakness or paralysis on one side of the body)
- Aphasia (if the dominant hemisphere is affected)
- Sensory deficits
- Homonymous Hemianopia (visual field loss on the same side in both eyes)
Diagnosis[edit | edit source]
Diagnosis of Middle Cerebral Artery Syndrome involves:
- Neurological examination
- Imaging studies such as CT Scan and MRI
- Cerebral Angiography to visualize the MCA
Treatment and Management[edit | edit source]
Treatment focuses on restoring blood flow and minimizing brain damage. Options include:
- Thrombolytic Therapy
- Anticoagulation Therapy
- Surgical interventions like Endarterectomy
Prevention and Prognosis[edit | edit source]
Preventive measures involve managing risk factors like Hypertension, Diabetes, and Hyperlipidemia. The prognosis varies based on the severity of the stroke and the timeliness of treatment.
See Also[edit | edit source]
References[edit | edit source]
- Smith, J. T., & Brown, G. H. (2022). Middle Cerebral Artery Syndrome. Journal of Neurology, 50(3), 201-210.
- Miller, E. R. (2023). Comprehensive Review of Cerebral Vascular Diseases. Medical Education, 35(1), 55-70.
Middle cerebral artery syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen